Patients often go without effective new treatments, especially in rare disease patient populations where profit potential is limited.
Bruce E
BE
Bloom
D035843:Biomedical Research / Q000191:economics* / Q000331:legislation & jurisprudence / Q000458:organization & administration; D055808:Drug Discovery / Q000191:economics; D006801:Humans; D035583:Rare Diseases / Q000191:economics* / Q000628:therapy; D014481:United States